Personal information

Activities

Collapse all

Employment (1)

Royal Orthopaedic Hospital: Birmingham, Birmingham, GB

2006-03-01 to present | Consultant Orthopaedic Surgeon (Oncology & Arthoplasty)
Employment
Source: Self-asserted source
Lee Jeys

Education and qualifications (3)

University of Liverpool: Liverpool, Merseyside, GB

2018-08-01 to 2019-08-01 | Doctor of Science (Medicine)
Education
Source: Self-asserted source
Lee Jeys

Cardiff University: Cardiff, Cardiff, GB

2000-08-01 to 2003-08-01 | MSc (Ortho.Engin) (Engineering)
Education
Source: Self-asserted source
Lee Jeys

University of Liverpool: Liverpool, GB

1990-09-01 to 1995-06-01 | MB ChB (Medicine)
Education
Source: Self-asserted source
Lee Jeys

Professional activities (2)

Aston University: Birmingham, GB

2015-01-01 to 2025-01-01 | Professor (Life & Health Science)
Invited position
Source: Self-asserted source
Lee Jeys

National Cancer Research Institute: London, London, GB

2015-01-01 to 2020-01-01 | Chairman (Sarcoma Clinical Study Group)
Invited position
Source: Self-asserted source
Lee Jeys

Funding (16)

A smart, multi-purpose technology for diagnostics, analytics and drug delivery.

2021-07 to 2023-12 | Grant
Engineering and Physical Sciences Research Council (London, GB)
Source: Self-asserted source
Lee Jeys

The Role of Oestrogen in Chondrosarcoma Using Patient-Derived Xenograft Mouse Models: A Pilot study.

2020-07 to 2022-07 | Grant
Bone Cancer Research Trust (Leeds, GB)
Source: Self-asserted source
Lee Jeys

A bioactive multifunctional material to aid the treatment of bone cancer

2019-01 to present | Grant
H2020 Marie Skłodowska-Curie Actions (Birmingham, GB)
Source: Self-asserted source
Lee Jeys

In vivo and in vitro evaluation of novel gallium doped bioactive glasses for the management of osteosarcoma.

2018-10 to 2021-10 | Grant
Sarcoma UK (London, GB)
Source: Self-asserted source
Lee Jeys

ICONIC: Improving outcome through Collaboration in OsteosarComa Study (Collaborator)

2018-03 to present | Grant
Bone Cancer Research Trust (Leeds, GB)
Source: Self-asserted source
Lee Jeys

Evaluation of single cell RNA sequencing in circulating tumour cells

2017-10 to 2018-10 | Grant
norwich research park (Norwich, GB)
Source: Self-asserted source
Lee Jeys

Modelling Ewing’s sarcoma heterogeneity and tumour microenvironment to improve outcomes

2017-07 to 2020-07 | Grant
Bone Cancer Research Trust (Leeds, GB)
Source: Self-asserted source
Lee Jeys

Single cell RNA sequencing in childhood bone cancer

2017-02 to 2020-02 | Grant
Humane Research Trust (stockport, GB)
Source: Self-asserted source
Lee Jeys

Exome sequencing and microRNA analysis in Paget's associated osteosarcoma

2017-02 to 2018-02 | Grant
Paget's Association (Manchester, GB)
Source: Self-asserted source
Lee Jeys

BCRT Tissue Infrastructure Grant

2016-08 to 2017-08 | Award
Bone Cancer Research Trust (Leeds, GB)
Source: Self-asserted source
Lee Jeys

MR guided Focused Ultrasound (MRgFUS) for Sarcomas

2016-06 to 2018-06 | Grant
Sarcoma UK (London, GB)
Source: Self-asserted source
Lee Jeys

Investigation of Gallium Doped Bioactive Glass

2015-07 to 2016-07 | Grant
Sarcoma UK (London, GB)
Source: Self-asserted source
Lee Jeys

Optimisation of circulating tumour cell detection in osteosarcoma

2014-01 to 2015-01 | Grant
CHILDREN with CANCER UK (London, GB)
Source: Self-asserted source
Lee Jeys

PREDICT study

2013-01 to 2016-01 | Grant
Bone Cancer Research Trust (Leeds, GB)
Source: Self-asserted source
Lee Jeys

Functional MRI evaluation of chemotherapy repsonse

2011-11 to 2014-11 | Grant
Bone Cancer Research Trust (Leeds, GB)
Source: Self-asserted source
Lee Jeys

CASSIS Study

2010-09 to 2013-09 | Grant
Bone Cancer Research Trust (Leeds, GB)
Source: Self-asserted source
Lee Jeys
How many people are using ORCID?